Abstract
Leucopenia appears to be a more frequent complication of sulphasalazine treatment in rheumatoid arthritis than in inflammatory bowel disease and poses a management problem. In this study leucopenia was found in 20 patients, 14 of whom were participating in prospective studies (252 patients), giving an incidence of 5.6%. Treatment had to be discontinued in half of these patients. Most (14) episodes of leucopenia occurred early in treatment (less than 24 weeks) but some occurred late and sustained monitoring seems necessary. No predictive factors for leucopenia were elucidated. All patients recovered fully with dose adjustment or, in more severe cases, after withdrawal of sulphasalazine and appropriate supportive therapy. The incidence of leucopenia may be higher in Glasgow than in other units in Britain.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ali A. T., Basran G. S., Morley J. Mode of action of sulphasalazine: an alternative view. Lancet. 1982 Feb 27;1(8270):506–507. doi: 10.1016/s0140-6736(82)91474-x. [DOI] [PubMed] [Google Scholar]
- Amos R. S., Pullar T., Bax D. E., Situnayake D., Capell H. A., McConkey B. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):420–423. doi: 10.1136/bmj.293.6544.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Capell H. A., Pullar T., Hunter J. A. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Drugs. 1986;32 (Suppl 1):44–48. doi: 10.2165/00003495-198600321-00009. [DOI] [PubMed] [Google Scholar]
- Carr-Locke D. L., Ali M. Glandular fever-like illness associated with sulphasalazine. Postgrad Med J. 1982 Oct;58(684):665–666. doi: 10.1136/pgmj.58.684.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danielson D. A., Douglas S. W., 3rd, Herzog P., Jick H., Porter J. B. Drug-induced blood disorders. JAMA. 1984 Dec 21;252(23):3257–3260. [PubMed] [Google Scholar]
- Williams H. J., Ward J. R., Dahl S. L., Clegg D. O., Willkens R. F., Oglesby T., Weisman M. H., Schlegel S., Michaels R. M., Luggen M. E. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum. 1988 Jun;31(6):702–713. doi: 10.1002/art.1780310602. [DOI] [PubMed] [Google Scholar]